Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hamari Chemicals Ltd
Zeria Pharmaceutical Co Ltd
Original Assignee
Zeria Pharmaceutical Co., Ltd.
Hamari Chemicals Co., Ltd.
Masaaki Hirano
Shirou Katayama
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP19164096Aexternal-prioritypatent/JP3877807B2/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Preventives/remedies for stomatitis containing L-zinc carnosinate salt or L-carnosin/zinc complex optionally together with sodium alginate. These drugs are excellent in the effects of treating and preventing stomatitis, in particular, one caused by chemotherapy or radiation therapy for cancer.
CA002259997A1996-07-031997-06-25Remedies and preventives for stomatitis
Expired - Fee RelatedCA2259997C
(en)
Aryl halide substituted metallic complexes, pharmaceuticals containing these complexes, their use for diagnostic purposes, and methods for preparing the complexes and pharmaceuticals